首页> 外文期刊>Head and neck: Journal for the sciences and specialities of the head and neck >Validation of the eighth edition American Joint Committee on Cancer staging system for human papillomavirus‐associated oropharyngeal cancer
【24h】

Validation of the eighth edition American Joint Committee on Cancer staging system for human papillomavirus‐associated oropharyngeal cancer

机译:验证人乳头瘤病毒相关口咽癌癌症分期系统第八版联合委员会

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Background The eighth edition American Joint Committee on Cancer (AJCC) staging manual includes major changes in staging of oropharyngeal cancer (OPC). We evaluated the new staging system in order to validate this shift in classification. Methods We used the National Cancer Database (NCDB) to identify patients with human papillomavirus‐associated (HPV‐positive) OPC from 2010‐2013. We restaged patients using the eighth edition guidelines and compared them with those from the seventh edition. We calculated stage‐specific overall survival and concordance indices. Results We identified 15?116 patients with a median follow‐up period of 29.1 months. Clinical and pathological staging changed for 93.9% and 91.7% of patients, respectively. Survival concordance indices for both clinical (0.621‐0.656) and pathological (0.640‐0.663) staging were improved in the eighth edition compared to the seventh edition. Conclusion The eighth edition guidelines have profoundly altered staging of HPV‐positive OPC and seem to demonstrate improved survival discrimination.
机译:摘要背景癌症(AJCC)分期手册第八版美国联合委员会包括口咽癌症分期的重大变化(OPC)。我们评估了新的分期系统,以便在分类中验证此转变。方法采用国家癌症数据库(NCDB)鉴定2010-2013的人乳头瘤病毒相关(HPV阳性)OPC患者。我们使用第八版指南恢复患者,并将其与第七版的那些进行比较。我们计算了特定阶段的整体生存和一致指数。结果我们确定了15-116名患者中位后续29.1个月的患者。临床和病理分期分别改为93.9%和91.7%的患者。与第七版相比,第八版本的临床(0.621-0.656)和病理(0.640-0.663)分期的生存令人互动指数得到改善。结论第八版指南对HPV阳性OPC的分期进行了深刻的改变,似乎表明了提高的生存歧视。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号